Kinpritma Sangha

Feinstein Institute for Medical Research

Papers

1

Total Citations

9

H-Index

1

About

Dr. Kinpritma Sangha is a rising leader in health technology assessment and stroke care innovation, whose work bridges clinical outcomes, cost-effectiveness, and health equity. Her primary research focuses on the economic and operational implications of remote robotic systems for acute ischemic stroke treatment, particularly endovascular thrombectomy (EVT). In her landmark 2023 study, "Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke," Dr. Sangha demonstrated that remote robotic EVT systems could significantly reduce time delays and improve patient outcomes by enabling thrombectomy at primary stroke centers, eliminating the need for transfer to comprehensive centers. This work, already cited 9 times, provides critical evidence for policymakers and hospital systems considering tele-robotic investments. Her contributions extend beyond cost modeling to address systemic barriers in stroke care access, particularly for rural and underserved populations. By quantifying both clinical benefits and economic viability, Dr. Sangha has positioned herself at the forefront of efforts to democratize life-saving stroke interventions. Her research is essential reading for health economists, neurologists, and healthcare administrators seeking to optimize stroke systems of care through technological innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke
9 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Feinstein Institute for Medical Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago